DOW JONES27,969.93-1022.48 -3.53%
S&P 5003,221.17-116.58 -3.49%
NASDAQ9,214.59-362.00 -3.78%

Morgan Stanley Reinstates Overweight on BeiGene, Announces $210 Price Target

Morgan Stanley reinstates BeiGene (NASDAQ:BGNE) with a Overweight and announces $210 price target.

Benzinga · 01/17/2020 13:15

Morgan Stanley reinstates BeiGene (NASDAQ:BGNE) with a Overweight and announces $210 price target.